AtriCure (ATRC) Operating Expenses (2010 - 2026)

AtriCure (ATRC) has 17 years of Operating Expenses data on file, last reported at $108.8 million in Q1 2026.

• Quarterly Operating Expenses rose 10.35% year-over-year to $108.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $420.4 million (up 6.73% YoY) and the FY2025 annual result came in at $410.2 million, up 5.85% from the prior year.
• Operating Expenses rose to $108.8 million in Q1 2026 per ATRC's latest filing, from $102.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $108.8 million in Q1 2026 and bottomed at $69.2 million in Q4 2022.
• The 5-year median for Operating Expenses is $92.2 million (2024), against an average of $89.5 million.
• The widest annual swing landed in 2022, when Operating Expenses surged 255.97%; it then decreased 4.01% in 2025.
• Tracing ATRC's Operating Expenses over 5 years: stood at $69.2 million in 2022, then climbed by 27.78% to $88.5 million in 2023, then climbed by 21.09% to $107.1 million in 2024, then decreased by 4.01% to $102.8 million in 2025, then climbed by 5.77% to $108.8 million in 2026.
• Per Business Quant, the three latest ATRC Operating Expenses figures stand at $108.8 million (Q1 2026), $102.8 million (Q4 2025), and $101.1 million (Q3 2025).

Peer Comparison